Leubine Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Leubine Cream is primarily prescribed for the management of tinea infections such as tinea corporis, tinea cruris, and tinea pedis. The formulation allows for effective penetration into the stratum corneum, ensuring targeted antifungal action with minimal systemic absorption. Application should be limited to the affected area and surrounding skin once daily, typically for a duration of 1 to 2 weeks or as directed by a healthcare professional. Adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the site of application. Leubine Cream is contraindicated in patients with known hypersensitivity to luliconazole or any component of the formulation. Caution is advised in pregnant or lactating women, and use should be under medical supervision. Proper hygiene and adherence to treatment duration are essential to prevent recurrence and ensure optimal therapeutic outcomes.